Show UniProt / TrEMBL protein name		View as list		View in Fasta format (Protein)

# Yersinia pestis biovar Medievalis str. 91001, 91001

>pCRY17 hypothetical protein
ATGATAAAGAAACTTAAAGTAATCATGTTGGCGGCAATAGTTACCGGATG
TTCATCGCCGCCACCTCCCGTTCCTGTAGAGTGGGATAAAGCCGCCGACC
CATTAAACACCAGTTTACCGCAATGGAGTGACAATAACGTTATAGTTCCT
TCCCCGACAGTTAACGGTAAATGGACATCATCAATCAGCGCACAAAGTTT
CTACGATACAATATGGACTCCAGCAGTATTTTACGCAGTCGCTCATTCAA
CACGAATTGTCGTCACTGCACAATCCGGTACTGATTTCTTTAATGCCAAA
AACTGGCTTCGCCAGAATGGCGCAAAAGGTGTTATTGAATACCAGCCTGT
CTTTAATTGTCTGACATGCAGAGAAACCACTATTTATTTCTCTCGCTAA
>pCRY18 hypothetical protein
ATGAAAAAAACCGTTATCGCGGCGGCTGTATTATGCCTGACCGCAGGAAT
GCCGATTTATTCCTTTGCTGCTGACCCGTGCGAAGTTGTTCTTTGCATGT
ACGGAAAAGCTACGGGTAATAGTGGTGGGAGTGAATGCAGTTCAGCAGAA
CGCGCATTTTTTAAAATCAACGCATTTAAAAAACACCATCGTTTTAATCC
GGGTAAAACATTCGATATGCGAAAAGAATTTTTAGGGGAGTGCAAAGCCG
CAGACCCTGAATCAATAAGCAAAATCCTTTCAAAATTTGGCAGAGTGAAA
GGATAA
>pCRY24 micrococcal nuclease-like protein
ATGAAATTCCGATCTCGTTTGCTTGTTTTTCTGCCCCTGCTTTTCCCCGC
CCTTTGCCTGGCTGACTTTTCTGGCCGTGTTGTTCGGGTCGTCGATGGTG
ATACTGTCCAGGTACTCACCGATGGCAAAATGATGAAAGTTCGCCTTAAC
GGTATCGATGCCCCAGAATCGGGGCAACCGTTCGGCCAGCGCTCGAAGCA
AAACTTGTTAAAGCTGGCCGTCCAGAAACAGACGGAGGTCATAGCCAACA
GTACAGATCGTTATGGCCGCTGGCTGGGAACATTGATGATTGGCGGTATC
AATATCAACGCAGAGCAGGTTAAAGCGGGTATGGCGTGGGCTTACCGCTA
TCATGGCCGTACCAGTGACGAAACAATGCTACGCCTTGAAGAAGAAGCCA
GACGCCATAGAATCGGGCTGTGGGCGTCACCTGATCCAGTGGAGCCGTGG
AAGTGGCGCAAACAGAATAAATAG
>pCRY23 putative mobilization protein mobC
GTGAGGGCTGAAATGCTTATTCATAACGTTGCAGAAAGGAAAGAAGCCGC
AAACAGAAAAATGCTTGCATTGCTGACATTCCTTAAAGAAGAAACATACT
CCGATTTTAAAACGCTGAAAAAAGTTGTGGGGTTCAAGGGTAAAAGTCAC
CGCCCAACGTATGCGCTACTGAATAAAGCGGTTGCATTGGGGTTTCTGAT
AAAACATGAATACCCGGTAATAGCCGGAAAAAAATCACTATGGGGGATCA
CCATGCAAGGGCTGGCGATGGTGGTTAAACCCGATGATAAAGTATTCCCC
GGTTATTTTGAGCCGGGGAAACTCAAATACTGGACACTGGAACACCGGCT
CCTGAATCATCGGGTCAGAATTGCACTGGAAGAGAAAGGCGGGCAAGGCT
GGCTTAATGGTGATCGGGGGGAGTTTATTGCGCGTTATCCTGGCGTTCGC
CATCGTCCTGACGGGATTATCACGTTAGATAACGGCGCAATCGTCGCCGT
TGAAACTGAGCGCTCAATGAAAACCCGCGCACGCTATATCAACATCATTA
ACAGCCATCTGGCGGCCAGCGATGCCGGACGCTGGCACTACGCGATGTAT
GTCATGCCGGATGACAAAACCAAAACATCGTTAATCCGGCTGTTTGACTC
CATCAAAACGGTAATGAGGAACAACGTTCCGGTGCCGTTCGACGCGAAAA
ACCGCGAAATGTTTCTTTTCCGCACCATTGATGAACTGGAGCAAGCAGCC
GCCAGCGGCGGCCAGTGA
>pCRY02 hypothetical protein
TTGGACCCCCTGATCTCTGTCTCTCCCGCCAAGTTGAAGCAGATTTCAGG
GGGTTTTTGCATTCAGGGGTTGAGCTTTCGCTTCACCCCCATCCCTGGAC
GCTATTACCGGGAACGTCCCACCCGCATGAATACTGTAAACGTCGGTAAA
TTACCACGACGTTACATTAGGATCAATTATCTCGCCAAAGATCCCGCAAA
AAACCACTCTATTTTATTACCAAAAATCATAAAGTTGTATGAATCTCAAT
AA
>pCRY30 putative membrane protein
ATGCAGCGCGATATTCATCGTCCTGCATCCACTCGTTATGCAGTTCTTTA
TGGCTTACCAGTTTCATTAAGTACCTCCGCTAACCGCTTTTTGGCGAGAT
CGATTTCTTTCGCTGGCGTTTTCTGTGACTTCTTGATGAAAACCCGGAGC
ATGATGATGGTATTGCCTTTGTGGTATACCCATATTCCCCTGGCTATGTC
CGTTCCCATCGTGCGGATCTCAAAAAGTCCATCGCCCAGGGGCTTTGTGT
CCGGTTCCCGCAGTAATCGGGCGTCATACTCCAGTTTGCCGATGAGACGG
TCAAACTTCACCCTGATTTTTACGGGTAATGCTGTGGCTTCTTCCCTGGC
TTCCGGGTGA
>pCRY19 putative dopa decarboxylase protein remnant
ATGATAAACGAAGATTTATTCATTAAGAATATACACTCAAAAAATCAGGA
CAGAATATCTGTAGCCCTAGTATATGACACGTTATCAAAAGAAGCCCACA
GAGGTTGTGGGCTGTATTACGAAATATACGAAAGCTGTTTTATCGGTCTT
TTGCGCGATCATCTTTCAGAACTTAATGAGGTTGACGCAAAAAAATTAAG
ACGCTATGCCGAAGGCAAAGGCACAAAAATTGATGATGCGTCCTACAGTG
AAGCACTGGAAGCTGAAAGGGAGTGCAGGGCTGAAATATACCGCGAGCAG
ATGTAA
>pCRY25 putative membrane prtotein
ATGATATTCGCTAAATTTCAGTCACTGACCCATAAGATAGACACAATGGT
TATTCGTGACATTAAACGGGAGATGCCGTTGAAATACTGGTCATTCAAAG
TGGCGGAATGGATCGCCAGAATCGGAATGATTGGCTTTGTTTGTACCTTT
CTTACGTATTTCGGACTCGGCCTCATCATGCAGCACTCAGGCCAAAACCT
GCCGGAATCGTTTACTGAGGGATGCGCTCAAGCCATCGTTGCATTGATAG
CTATTGCCCTGGTCGGTTTCCTGGTCAGAGGCGGATTGTACGTCGATCTG
GAAAAAAGAATACTGGATAAGTGGCAGAGCTACGTTCAGTGA
>pCRY20 hypothetical protein
TTGTACAATACACAGACTAACAGGCGACAGGATTTTAAGGCTTCATTATT
TTTGGCTTCAATTTCGAAGAAATTGTTAAGACGAAAAATAATGAAGTGGT
ACGCGGAAAGAAAATTCAATTTCGGAGAAATTGCTAATTTTCAGGAACCG
CGCCCACCTGCGAACATTCGCCCACAGCGAATTGAGCAGGCCGGGGGGAG
CCGCAAAAATTTTGCCGCCCCAGCGAGCAAAAAGGCACGCCCACGTGCCG
GTTTTTGTGGGGGGCTTGCCCCGCACACCGTCGCAGCCAGGTAA
>pCRY11 hypothetical protein
ATGCGTTTATTAACAATATCTCTTCTGACATTATCAGTTTTCTTAATTAG
CGGATGTAAAGAAGAGGCTAAAACAACTAAATGGTATAAAGACCATCCAG
AAGAACTAAAAGCTGTTTATGAAAAATGCCAAAAAACAGGAAGCGCTTCG
GAAAATTGTAAAAATGCAAACGAAGCTCACTGGCAAATACAACAGTTGAA
TGCTCCGACCGTCGATTTAAATTCATAG
>pCRY25 
TGCGCTCAAGCCATCGTTGCATTGATAGCTATTGCCCTGGTCGGTTTCCT
GGTCAGAGGCGGATTGTAC
>pCRY26 hypothetical protein
ATGGCGAACGTCCCAGCAAAACCGCGCAATACCAAAGGTGAGCCGCCAAG
CCAGGCGGATACGGAACACGGCTTTAATCCTACCCGGAAAAGTGCTGATG
GCCGTAAGGCACAGCTTAACTTATACATTGATATGGAGCTGAAACGTGAG
TTCCGCTCCATTGCTGCGGCCAACGATATGAAACATGGGGAGCTATTCGA
GGCGTACCAGGAATTCTGGAAAAAACACCATTAA
>pCRY05 hypothetical protein
TTGCACCGCAGGCTTCATAAGCTGCGGTGCTTTTTTCATAGGAGTTTTTA
CCTCATGCCGAAAAGCGTACCAGGCAAATCAAGCACGGCTGTTATTTACA
TCGGGCAAAAGCGCTATCAGGAGTTAGCAAAGCAAGCCCGTGAAATCAGC
TACCTGTCTGAATCAAATATCCGGCCAAGCACCTTTCTCCAGTTCCTGAT
GGATGAATTTGGTGAGCAAGCCCGTACAGAGCTGCTCCGGCAGCTACTCG
CAGAGAAACAAAAGGAGTAA
>pCRY25 
ATCGCCAGAATCGGAATGATTGGCTTTGTTTGTACCTTTCTTACGTATTT
CGGACTCGGCCTCATCATG
>pCRY18 
GTTATCGCGGCGGCTGTATTATGCCTGACCGCAGGAATGCCGATTTATTC
CTTTGCTGCT
>pCRY06 putative ATP/GTP-binding protein remnant
ATGAGAAAACCCACCTATAACGTGTACGTCACGCAGGAAACCCAGCCCGA
CGAGAACGGCGAAAAAAATACGTACTGGACGAAAGTCGGTGCGGCCTTCG
CACACAACGGCAAGTCGGGGCTGAACATCATGATCACGCCCGGTATTTCC
GTTTCCGGCAAGCTGGTACTCCTCGAACCTAAAGATGACGCAGCGCCGCA
GGCTGCTCCTGTCAGTTAA
>pCRY21 hypothetical protein
TTGGTCGCGCGTAGCGCAAGACGGTGTGCCGCCTTTGACCTTGGGGGTTT
TGGCTCGGCGTTCAGCCGGGACATTACCCCCATGTGTCATGCAGTGAGGG
CGTCCAGCCCGAACGTAATGGCACACGCCGTTGCCCGTCATTCGGGCGTT
TCAGAGGACAGACGACCACTGGTCGGCTGTATTCTGAAAGCGCGGATAAC
GGGCTTGATCGCCACTGGCGATCAGCGCCTTTTTCCTGTTCATCGGAGCA
TATTATGGGAGCATCGCATGGGAGCGTGGTTACGCTCCTATAAGCTGCTC
CCATCTTTTGCGCCCAACACGTCAGTTTTCGTATGGAGAAAATAG
>pCRY30 
TATGCAGTTCTTTATGGCTTACCAGTTTCATTAAGTACCTCCGCTAACCG
CTTTTTGGCG
>pCRY22 putative mobilization mobB protein
ATGGAGAAAATAGATATGGGTTCCCACCTGATGCAAAGGCTGAATGCCTT
TGCCGATGCATTTTCCTTTTTTCTTTTATGGCTGCAAAACAGCCCTGTCA
TATTATCCCTGCTCGCAGGTCTTACATTACCTTTTATATTCCACCTTCCC
CGTGAGGAAAGAAAGAACGCCCCGTTCTGGTTAAAGTCGGTGGCGTGCGT
GTCCATTTTCTTTTTTATATTCGGCACCATATCACCGCTAACTATTCAGG
GGTTGAGCTACTTTTTTAAGTCACTCGACAACAACATACTGTTTAGAGTT
CCTCTATGGATCATGACCATAATATTTACGGCAGCAGGATTAATATTTCA
TATTGCAGCCCGACGACTTTTAGCAGGAGAAATTGACAACCTAAAACATC
GAATGATTAAGAAAAGCAAGCTGGAGAGAAATACCCGAACCGATGTACGC
AAAGTAAAAGAGTTATTGCCCGACAGCATAGAATACAATCCACTCGATTA
CATTGATTTAAAGAAAGGTGTTTTTATTGGCTTAAACAAAGATGACCAGC
CGCAATACATAACCATAAAAGAATTTAAAACCCAACACGCAGCAATTATC
GGTACAACAGGTTCCGGGAAAGGCGTAACTGCAACCGTTCTACTTTATCA
GGCTATTCTTTTAGGTGAGGCTGTTTTTGTAGAAGATCCAAAAGATGATG
AATGGGCACCACACGTACTTAGGGAAGCATGTAAAAAAGCAGGCAAGAAA
TTCACACTTATAAATTTAAACAAGCTAAATTTCCAGCTTGATTTACTGGC
TGATATCTCTCATGAACAACTGGAGGAATTATTTAACGCTGGCTTTAGCC
TGGCTAAGAAAGGGGAGGCGTCAGATTTTTATCGTATCTCTGACCGTCGC
GCAGCCAGAAATACATCTGCAATTTATGAAAACGGAATGACGCTTCGTGA
TTTATTTAACACTGACTTTGTTCAGTCATTACGTGAAGATGTTCCCGCAT
TTTGTGGCGAGCTGGAAGAAATTGCTTTAGTTAACTCAATTAATGCCAAA
AATGGATTTTCATTAAAAGAGGTTTTTGATGAAGGTGGTTGTTGCTACAT
TATTGGTTCAACGCGAAATCAAAAGATAATTTCCGCACAAAGAATGATTC
TGACCCGGCTGATACAAATAGCGGAGACCAGGGACAGAATAAACAGTACC
CCGCGTACTGTTGCTATTTTCCTCGACGAGTTGAAATATCATCTTTCTCG
CCCTGCTCTTGAAGGACTTGGAACGGCACGAGATAAAGGCGTGCATATAT
TCATGGCTTTTCAGGCGATAGACGATCTGCGTGACTGCCCGTCTGATTTA
AATGGTGATTCAGTTATTGGCGCTATCATTGAAAACGCCAAATTCAAATT
AATTTATAAAATCCAGAATCCCGAAACAGCAGAATGGGCGGCCAAAATGA
CAGGCTCTATCCTGGTCGATGATGAAATGAGAAAAGTACGGACTGATTTA
TCATTAACGGAAAAAGTGGATACAGACCGAATGATAAGACAGGCAGAAAG
TTACTACGTTGACAGTAATATGTTTTTAAATCTCCCTGAAAAAGTTGGTT
TTGTATTTACGTCAACCGAACTACCAAGAGCTACAAAGATGTTTCAGGTT
CAGGTCAAAAAAGAAAACATCGAACTTCTTTCATTTGAGTATAAACAAGC
CACACCAGAAAAAAATGAAAGTCAGGAACATAAGCCATCAATCAATCTGT
GA
>pCRY30 
ATGATGGTATTGCCTTTGTGGTATACCCATATTCCCCTGGCTATGTCCGT
TCCCATCGTGCGGATCTCA
>pCRY03 hipB1, putative transcriptional regulator
ATGGTTCCAAAACGTTTGAAGGAGGCGCGAGAGGCCGCTGGTTTATCCCA
GGAAAAATTATCTGAACTGGTAGGGGTGGAAGGAGTCAATCCTCGGTCAA
GGATGTCTAATTATGAAGCTGGACGGTTTGCACCTCCGTTTGAGTTCGTA
TGCCGTGTGGCTGATGTGCTGGGATATCCAGAGTATTACTTCTATATAGT
GAATGACGTTACAGCGAAGCTTCTTCTCCGGATGCATAGAGGAGAACAGA
ATTTGCATGAAGACATTGAGTTTGAGGCAAAAAAAATGGCTGAACAGCTT
GAGGACGCACGAAAACTGGTCGCCCAGCTTACTGAATGCCTGAAACATCG
CCCGTAA
>pCRY29 hipB2, predicted transcriptional regulator
ATGAAACTGGTAAGCCATAAAGAACTGCATAACGAGTGGATGCAGGACGA
TGAATATCGCGCTGCATGGCAGGAAGAAGAACGCAAGGAGAAGCTCAGAG
AGCTACTTGCGGAATGGCGTAAACATGACAACCTGACAAAAGCGCAGGTT
GCCGAACGCATGGGAGTTACACCTCCGGTTATTTCCCGCCTGGAAAATAA
CATCACCAAAGCCAGCATCGACACACTGACCCGCTACGCTCACGCCTGCG
GCATCAAGAAACCTGTCATTGCCCTGTACTGA
>pCRY28 mpr, zinc metalloproteinase Mpr protein
ATGACTTCGGTCACGGTGTTGTTTGCCGCCAAACCCTACAATTGTATTGT
GCAATACAATTCATATGGAGATAGTGTTATGTCCGATATCAAACCCGCAA
TTAAGGCATACAGTGAGCTTCAACAGGCTTATGACTGGTTCAATCTTTCC
CTCTTTGATAAGGCTCTGCCGGATCTGCTGATTACGTTACAGCGCGGTCG
TAACACCTTTGGTTATTTCGCGCCTGAACGCTTCACAGGGGAATCCAGCG
TATCGGAACTGGCGATGAATCCCGATTACTTCGGTGGCCGTTCGCTGGCC
GATACCCTGTCAACACTGGTACATGAAATGGTGCATGTGTGGCAGCATTA
CGCCCCGGTTAAAAAATGCCGGGGTGGCTATCATGATCGCGTATGGGGTG
CGAAAATGGAGGAAGTCGGGCTTATGCCATCAAATACCGGCTTACCTGGC
GGGAAAAAGAACGGGCAGCAGATGACGCACTACATTATCCGTGGTGGCCG
CTTTCAGAAAGCCGTGTATGACCTGCTTAAAAATGGCTTCTCTATCTCTT
GGTATGACCGCTGGTCTGACGGGGCAATTGTTACCTCAAAGATTAACAGC
GATATCCTCGATGACTGGCTGGCCGTCACCGATGAAAACGATACTGACCT
TATCAATCGGCTATCACTGACCGTCAGCAAATCCCGCCCGGAACTCATTC
CAGACGATGACGATCTCAGCGTCATGATCAAACCGCCAGTAAAGGGTACT
GGCACCCGCATGAAATTTACCTGCCCGGAATGTGGGCTGAACGCATGGGC
GAAACCCTCCGCTGTATTGCTTTGCGGTGAGTGTCGGTGTGAGCTTACGG
CGGCAGAATAA
>pCRY04 nusG, transcription antiterminator
ATGTATGAATGGTACGTTTTATACTGCAACAATCAGGATGTTGAACGCAT
CACCCGAAGAGTCGAGGGACTGAATGTCGAGGTGTTTTGCCCCCGCTATA
TCAAAGTAACGCCACGTAAGGATTGCCGGGCGGTACGTCAGGAAGAGAAA
GTGTTGTTTCCTAATTATCTTTTCCTCTGCTTTGACGTCAACATAACGCA
TACATCGACTATCACATCAATTCCGGGCGCGCATGGTTTTGTCAGCTTCG
GTTCAACACCCTGCACCGTCCCCAAATCAGTGATAACAGCGATTGAATGC
GCCCGTCTGATGGCGCTCAATCCTGATGAAGATGCTATCGAGTGCCGAAA
TATCGCCCCGGATTTGCTGGCAAAAATTCAAGAACTCTCCCTGATAAGGT
CTCCGCTCCAACGCCAGGTAGCCTTTTCAAAACTACTCCAGAACCAATAC
CACTAA
>pCRY27 parA, ATPases involved in chromosome partitioning
ATGACCGCTGTTATCGCGCTGGCTAACGGGAAAGGTGGGGTGAAAAAGTC
CTCGATGTCACGGGCTATCGCCACCGAGTATACAAAGGCAGGATGGGGGG
TTCTTGGGCTGGATATGGATATTGATCAGGGGTCTTTCCTGGACTGGGGG
CAACGTAGGTTGCGGAATGGTTTTGAACCTCCGGTGACAATTCAGGGATG
CGGGACGGTTTCACAGGCGAAGAAACAGATCGAATCCGGGCAATGGGATT
TGATTGTCATCGACAGTGCGGCGTATGCCACGAAATCGTTACTCAGCCTG
ATTGATATTGTCGATTTGCTGGTACTGCCGACAGGGTTTAGCGTGGATGA
TCTACGAACGACCGTTACGACCGTAAACGCGCTGCGTAACAAAGGACATT
CGACAGATAAAATGGCGGTGGTGTTTGCGGGGGTAAGTGAAAGTGAGAGT
GAATATCGTGCGGCGCTGGAATACCTGCAACCCTGCGGCGTTCCCGTCAT
TCCGGGCGCTATTCCTTTTCTGACATCGTTCAGCCAGGCGCAGGATAAAG
GGCTTGCTCTTACGGAGTCTCCTTTCCCTGGCCCACGGCAGAAAGCTGAT
GATGTTGTGCAGGGTGTGATCGACCGACTGACAACGCTTACGCAGTAG
>pCRY01 repA, putative RepA protein
GTGCGGGCGGGTGTGACTGATAAGAGTCTCTCTCTCAAATCGTCCGTATC
ACCTACGGGCGTCGCAAAGCAAAGCCCCTGTTATAACGTTGCCTCGCGCA
AGCGTCGCCGGTTCCTCAATCGGTGGATTAAGTCGCTGGCGACCGAAGCC
GGGCGTATCAAAATCAAAAACGAACTTCGGCGCCGCATCCGGCACAACAA
GTATTGGGTCAATGAAGCGAACAAGTTCGGGCTTGAGGCTCTTTGCGAGC
TGATGTTGGCCATCCTTGACGATCTGGATTTAAGGGACTGGCAAACCATA
CATAACCTTGAAACGCTGGCCGACCGTGCCGGGCTGACGACGCGCAGTGA
TGCGGGTCACAAGTCGATTTCTCGTGCCAGCCGGGGATGTGATCGCCTCT
CCTGGCTTAATGCCATCATCTCGGAAAAAGCCCCCTTCAATCCTTATGAC
GCCCGCTGCGCCTGCAAGCACATCGAGGTTACAGAGGATTTCTTCGCCAT
TCTCGGCATCCCGCTAAAACAGGTTTACCGGGAACGCGCCAGGCTGCTTA
AGGCCAACCCGGAAGAAATCATATCCTCCGGGGATGTCCGGTTAATCGCT
ATCAAGGTTGAAAACTGGACGCGCAAGGCCGCAGCCGGATTAGCCAGGAT
GAAAGCGAGGCGTGACGCAGCTCGCCAGCGCAAACAGGAATACTACTCCC
CAACCTTTGCCTGA
>pCRY07 virB1, type IV secretory pathway VirB1 component
ATGCTTTCCACCACTGCTTTTCTGGCGGTGGCTATGCAGTGTGCCGCCAC
CGTTCACCCTTCTACGTCCCTCGATGTGGCAAGGGTGGAGTCCGGTTATA
ACCCCTATGCCATCGCTGAGATCGTGCCTAAGCCCGAACGAAAACCCGGC
GATAAAGGCTTTATTACTCACATGCCAAAAAGTAAGGAGGATGCAGTCAG
CATCACTAATCAGATTGAGGCGAAAGGTCGCCGCTACTCTGTTGGCCTGA
TGCAGATAACCAGCACCAATTTTAAGCGTTACGGCGTCACCGCTACTGAC
CTTTTCAATCCCTGCATCAATCTTTCCGTCTACGAAAAAATCATCACCGA
CTGCTACCAGCGGGGCGGCACCCTGAAAAGGGCGTTGAGCTGCTACTACT
CCGGCAATTTCAGTACCGGACAACAGCAGGAACCCGCTTTTTCAAAGACG
AGCTATGTACAGCGGATTGGCTACTCCCCGGCGGATACCCACTATGCCGT
TCCCGGCACCCGCGATGATATCGCAACCCCAGCGGCCACCCTGAAAGCTA
CGCCAGTGGACGCGCCCACGCGCCCACGCGTGGTGTGGCCGGGGGCGATC
GTTCGCGGCGTTCCGGCTCAACTCCGCCAGAAAAAGGCGGCCACCGTCTA
TTACCCCGCGCAAGTTGTGCGCGGAAATCGCGATGTAACAACGAAAGAGG
AAGAAAAATGA
>pCRY15 virB10, type IV secretory pathway VirB10 component
ATGAACGACGAAAACAAAGTGCCTGTGCCGGATGAAGCGCAGGCATCCCC
GGCACACGCTGAGGATGATATTGCCACGCTTGAGCGGGAAGCCCGCGCTA
AAAGGGAGGCCGAGCTTCTCAATGCGCAGGACGACGAAGAGAAAGACCCG
GTACAACCCGCCGTTAACAAGCTGAAAAAGCGCAAACGGGGCAAAGCAAC
CGCCTTTCTTGCCATTGTCGCGGTCGCGCTTATCTTCCTGGCATGGGGGG
GTAACTGGGTTTATCGCAATATCCTGTGGCAACCCACGGAAGAAAAGAAA
CAGGACACAGCCCCGCAGACGAACAAAACCGATTACCGGCAGCGTAACGA
TCTCGGTATGTCCACCGATACAGCCGAAAAAGAGCCAGAGCAGCAGGATA
ACGGCCAGAGCAGCACGGGGGGAACAGGGCAGGCGGCTCCGGCCGCCCCG
CCAGAACTCAACAAAGCCAGCTTCCTTATTCGCCGTGATGGTTCAGCCAC
CACACAGAACCAGGTAAAAACCCGGCAGCAGGAAATGACGCTGACATCGG
CAACGACCACCGGACAACAGGACAGCAGCGCGGCCACAAATACCGCCGCA
CCGTCGCCGGGACAAAGCCCCGCACCAGTGCGCCGCATACCCTATAACCC
TGACCTGTACATCCCGGAAAATACCTCGATCCCCTGCTCACTGGATCGCC
GTTTTGTATCTGACCGGGCGGGGAAACTTCGCTGCACGGTCACTACTGAC
ATCTGGAGCGCCAGCGGCAACACGAAGCTGATAGAGAAAGGCACCACGGC
ATCATTACTTTACCGCGCCATAGCGGAAGAAGGTATGAAGCACGGGCAAG
GGCGGGCATTCATCATTGCGACGAAGCTACGCACCCGCCAGCCGCCTTAT
CTCGATATCCCGTTGGTTGATACCAGCGCGGCTGGCGAGCTGGGCGAGGC
TGGCGTTGATGGCTGGATAGATTCGCACTTCTGGGAACGGTTCGGCGGCG
CGTTAATGGTCGGCATGATCCCCGATATTGGCGCATGGGCATCCAACAGT
GCAGGTAAAAAAGACCGCAATACGGACTATACGGAAAACAGCCGCCAGGC
TATGGCAGATATGGCGCGTACTACGCTGGAGAACAGCATCAATATTCCCC
CAACGCTCTATAAGAATCAGGGCGAGATCATCAACCTGATCACAGGCGAG
GATATTGATTTTTCCAACATCTATACACTGAGGTTGAAAAATGACCGCTA
A
>pCRY16 virB11, type IV secretory pathway VirB11 component
ATGACCGCTAAGAATATTTCCCTCGACCGCTATAAACAGCGTTTCTTTGG
CGACTTTCTGGAGCTTCCCGGCCTGACGGAGATCGCCGTCAACCGTCCAG
GTGAGCTGTATACCAAAATCAACGGCGTATGGGAGCAGCACGCCGTTCCT
TTGTCCTATGAGGATTGCTACAACTTTGCCCGGTGCCTGGCAAAGCACCA
CGGCGACAATATCGAAGATATTAAGCCGGGGCTGTCAGCCACGCTGGAAT
CTGGCGAACGGTGCCAGGTGATTGTTCCCCCGGCCTGTGAGCGCGATACG
GTGTCTATCACCATCCGTAAGCCATCAAAGGTACAAATCCCGCATCAGTC
GTATATCGATGCGGGATTTTATAACCGGGTAACAGGCGAGGAAAAAACGG
AGACGCACGACGAGGAATTAATTGCATTGTACAATACAAAAAATATTCCT
CTGTTTATGGAGAAATGCGTCGAGTACGGTAAAACTCTCGCGGTCGCCGG
GGAAACAAGTACCGGGAAAACCACCTATATGAAAATGTTGATAGGGTATA
TTCCTGTACATCTTCGGATATCAACCATTGAGGACAACCCGGAAATCACG
TTCTTTATCCATAAAAACTACGTCCATCTTTTTTATCCGTCAGAATCATC
AGATGAAAAAGGTTCTATCGTTACCCCAGCGAGCCTTTTACGCTGGAATT
ACCGTATGAACCCTGACCGCATTTTATTAACGGAGGTTCGCGGTGCGGAA
GCCTGGGACTTCCTTAAAATAACAGGTTCCGGCCATGAAGGGAGTATGAC
CTCCATTCATGCAGGATCAGCGAAAGAAGCTATAGATGGGTTTATTACCC
GTTGCTATGAAAATCCACAGTGCGCCCAGCTCCCCTATACATTTATGTTA
CGTAAGGTTCTGGATAGCCTGGACGTGATTGTGAGCATTGATTTAGACGG
AAATGTCCGCCGTATGAATGACATCTATTTCCGTCCAATTCATCGAAACC
AGTATTTTGAGGAAATGAAAGCATGA
>pCRY08 virB2, 
AAGGTATCCAGCGGGCTGCATGGTCTGGCGGCTATCACGATCACCGTGGC
CGTGATCTGGATTGGTTAT
>pCRY08 virB2, 
TTAATCAGCCGTGCATCTGCTTATATTCTGGCTCCGGCCATGAGCGTTTT
TGCAACCAGCCCGGCATTC
>pCRY08 virB2, 
TCGCAATGCGGCTACATCATCATTGGCGGCATTTTAATTGGCGGAGGCAG
TGAAATCGGCGCTCTGCTG
>pCRY08 virB2, type IV secretory pathway VirB2 component
ATGAAACTTTTCAGTAAGGTAAAGGAATTAATCAGCCGTGCATCTGCTTA
TATTCTGGCTCCGGCCATGAGCGTTTTTGCAACCAGCCCGGCATTCGCTG
ATGGTTTTAGCCGGGCAAATACCATCATGGAGAAGGTATCCAGCGGGCTG
CATGGTCTGGCGGCTATCACGATCACCGTGGCCGTGATCTGGATTGGTTA
TAAGACCCTGTGGAAAGGCGAGAGCCTGTCGCAATGCGGCTACATCATCA
TTGGCGGCATTTTAATTGGCGGAGGCAGTGAAATCGGCGCTCTGCTGATG
AGCTGA
>pCRY09 virB4, type IV secretory pathway VirB4 component
ATGGTGCCCCTGCTGGCTGTCACAGGTGTAACCATCATCGTTGCTATCTG
GACTTCCGTCGCTCTCCTGTTCTTACTTCCTGTGGAATTTCTGGTGATGA
AATCCCTTACCAGAAATGAACCGATGCGGTTCAATCTGATTGCCGTATGG
CTGAGAGCGAAGGGAAAGCCGGTAGCAAACCGTTTATTTGGCGCAACAAC
ATTTATGCCCGTTGAGCATGATGATGTTGATATCAAGGAGTTTCTCGACG
CCATGAAACTAAATCAGTGTGCCACCATCAAGAAGTACATCCCGTACTCA
TCGCACATTCATCAGCATGTGGTTCGTTCCCCTAAGAGCGATCTGTACTG
CACCTGGGAATTGATGGGGACGCCGTTCGACTGCGAGTCTGACGAATCGC
TCCAGTTCGGGACGAACCAGTTACACGGGTTAATCCGCTCATTCGAAGGT
ATGCCCGTCACTTTCTATATCCATAACGACCGCAATACGTTTACCGACAA
TCTTCATCAAGATTCAGGCAACCCGTATGCCGATGAAGTTAGCCGTCTTT
ACTACGCCTCTGTTGGCTCGTTCCGGCGTAACCGCCTGTTTTTGACGGTC
TGCTATCGCCCGTTCGTCAGCCTTGAAAAAGCGGAACGCAAACGGATGAA
AGACCGCCAGAAACTTAAGGAACTGGACGGTGCATTGCTGGAAATGCTGG
AAATCAAAAGCACGCTCGATACCGCGCTGGCGCGCTATGGTGCTCGTTCT
CTCGGCACGTTTACCGAAGGAAACATGGTGTTTTCGTCACAACTGGCATT
CTATGAATACCTGTTAACTCACCAGTGGCGAAAAGTTCGCGTCACCCGCA
CCCCGGCCTATGACGTGATGGGCGCGGCGGCGTTGTTCTTTTCGGCGGAG
TCAGGGCAGATAAACCACGCAAACGGTACGCAATATTTCCGGGGGCTGGA
GATTAAGGAGTTCTCCGAAGAAACCGCCACGGGGATGATGGACTCCCTTC
TTTACGCCCCCTGCGATTATGTGATTACGCAGTCCTATACCTGCATGTCA
CGCGAGGAAGCGAAAAAAGCCATTAAGCGTACCCGTCGCCTTTTGATGAG
TGCCGACGACGATGCAGTTTCCCAGCGGCTGGATCTGGATGTGGCGCTTG
ACCTGCTGACATCGGGGAAAATCGCTTATGGAAAGCACCATTTTTCCATC
ATGGTGTATTCCCCGTCGCTGGAAAGCCTGGTTGCAGATACTAACGAAAT
CAGTAACGCGCTGAACAACATCGGGATAACGCCTGTTCCGGCAGAAATAT
CGCTTTCAGCGGCGTATATGGCGCAACTGCCAGGCAACTACAACCTGCGG
CCACGTAAAGGGGAACTGAGTAGCCAGAACTTTGTGGAGCTGGCCGCACT
CCATAATTTCTATCCGGGCAAGCGCGATAAAGCCCCCTGGGGGTATGCAA
TGGCTTTGATGCGCACCCCGTCAGGTGACGGCTACTATATCAACCTGCAT
AACACACTGGCAGATAAAGACGAATTCAACGAGAAGAACCCGGCCAGTAC
CTGCATCCTCGGTACGAACGGTTCTGGTAAAACCATGTTGATGACGTTCT
TTGAGATCATGCAGCAGAAATACGGGCGCGAGGATAGCTTCTCCCCGGAT
GCCAAAACCAAACGGCTGACAACCGTTTATCTCGATAAAGACCGGGGCGC
GGAGATAAACATCCGGGCGCTGGGTGGCCGTTACTATCGGGTTATCAGTG
GCGAGCCTACAGGGTGGAATCCGTTCTCACTGCCTGCAACCAAACGCAAT
ATTAACTTCATCAAACAACTGGTGAAAATCCTTTGCACCCGTAACGGCGC
AACCATCACTCCCCGTGATGAACGCCGTCTGAACGACGCGGTTAATGCCG
TCATGAGCGATGAGCCAGAGTATCGCCGTTTTGGTATTACCCGACTCAGG
GAACAGCTACCGGAACCAGCCACAAAGGAAGCCCAGGAAAATGGCCTGGA
TATCCGGTTGTCACAGTGGGCGCAGGGCGGTGAGTTCGGCTGGGTGTTTG
ATAACGAATCTGACACGTTCGATATAAGCAACTGCGATAACTTCGGCATC
GATGGAACGGAGTTCCTGGACGATGCAAGCGTATGTGCGCCAATCTCGTT
TTACCTGCTGTACCGCATTACCAGCCTGCTTGACGGGCGACGCCTGGTCA
TTTTCATGGATGAGTTCTGGAAGTGGTTACGCGATCCGGTGTTTAAGGAC
TTTGCTTATAACAAGCTGAAAACCATACGTAAGCTGAACGGGATGCTGGT
TGTCGGTACTCAATCCCCGGCAGAGATCATCAAAGATGATATCGCCCCGG
CAGTGATTGAGCAGTGCGGGACACAGATTCTGGCGGCGAACCCCAACGCC
GACCGCGCACACTATGTTGACGGCATGAAGTTTGAACCGGAAGTGTTCGA
CGTGGTGAAAGGGCTTGATCCGCAAGCCCGCCAGTATGTTGTGGTGAAAA
ATCAGTTCAAGCGCGGCGATACCAAACGTTTTGCCGCTCGTGTCACGCTC
GACCTGTCGGGTATCGGCAGATACACCAAAGTCATGAGCGGCGATGCCCC
CAACCTCGAAATATTCGAATCGATTTACCGGGAAGGAATGCAGCCTCATG
AATGGCTCGATACCTACCTGGCTAAAGCGCTCTGA
>pCRY10 virB5, type IV secretion system VirB5 component
ATGAAAACTCGCTTTCGTACCCTTATTCTGGCTTGCGTCATTGCAAGCCC
ATTGGCTCATGCAGGGATTCCCGTACTGGTTGATGCTGACCCGCTACGTG
AGGCTGAATGGCTGAAAGAGGCACAGCGCTGGATGGACACAGCGAAGCAT
TACCAGAGCCAGATACAGGCATACAAAGACCAACTGGCGACGGCAACAGG
CGTTCGTGATATTGCCAACTTTGTTGACCAGGCCAAAAGCCTGAAAGCCG
ACCTCGAAAAGCTACGCAAGCCCGGACAGGCACTGAATGATTTGCTCCTC
TCCGGCGGTTCCTCCGGGCAGTTCGATGCGCTGTACGAAAAGTATAAAAT
TTTCGATACCTGCAACACAGCACAATCAGGGAGTTACGCCAACGTATGCA
AACAGCAGGTAATCAATAAAGCAATCCAGCTCGAACAAACTGACGAGATC
CAGAATCAGGTAAGCCAAACCTTGGGGGAAATCAACAGCCTCTCCAACAG
GGTAGCGTTAGCCAAAGATTCGAAAGAATCTCAAGACCTTGCAAACAGTA
TTCAGCTAAAATCTGTCATGCTGAACACGCTTACCACCCAATGGGAAATG
AGTGTGAAAGCAGCAGAGAAGCGCGAAAAAGTGCTTGAGGCGGAGCGTGT
TAAACAGTGGAATCAGCAGCAGTTAACCGCACCAACAGTTGATTTAAATA
GCTAA
>pCRY12 virB6, type IV secretory pathway VirB6 component
ATGTCCGGTGGTGTTTTTGTCGGTGTTGAAAAACACCTGATAGGAGGAAT
AACAGACGCCACAAAGGGATTAATGATGTCGTACTCTTCTATGATGATGG
GGCTGGCAGCAGCGTCAGCCACCATCTACATCATGTGGCGGGGATACCAG
ACTCTGGCTGGTAAGCTCTCTACACCGATGGAAGACACGATGTGGGACAT
CATGAGGATGGCGATCATTCTGTCCTTTGTGGCTAATTTGGGTGGCTATC
TCGATGGCGTTATCGACGCTGTTAATGGGTTAAAGGAGGGGTTTTCTGGC
AGTGATAATATATGGCAACTATTAGATAGCTTATGGAATAACGCAAAAGT
ATTAGGTAAAACATTACATGACATGGATAATTCTACATATATAAAAGATG
AGGGAATGACCGCTCAATTTTATGTATGGCTTGGGATATTCGTCTTAATG
ATTATTACCGCGTTTGTTTCCATGATAGCGGAAGTCATGATCTTATTGTT
GAGTATCACTGCACCTATATTTATATTTTGCTTAATGTATGGCTTTCTAC
GCCCCATGTTTAATAACTGGCTACAAAATATATTTGCAGCCATATTAACT
ATTCTCCTTTCCTCTTTATCATTAAGGATTGTAGTCAATTATTTAAACTC
AAGGCTTGCATTAGCAACTCAAGGTGCAGCCCAGGCAAATATTGTAGAAC
TAGGAGCACAAGTCTGTCTTGCTGGTATCTGTGCGGCAATATTGGTTTAT
CTCTCCGCAAAACTGGCCGCAGCACTGGCCGGGGCGAGTGCTACCGTATC
CATGCAGGGGCTGGCCGCTGTAGGTATCGGTGCTGCTGCTTTTGGTGCCG
GGAAGCTGGCCGGGGGAGCCGTTAAAGAAACCAAACGTTCCGCCCAGGAC
AACATTCAGGGCTGGAAGGATGCGAATGCAGGTAAACCCGGCAAGCCCGG
AGGTGAGTTAGGCTATAACGCTTCTAAAGCGCGTAAATACGCGATTGAGC
AGATGATAGCCCGGAACGAAGCGCGGAGGCTGGCACAGTCGAGAGAATCC
GCGGTTAAGAAGTTCAACAGCTAG
>pCRY13 virB8, type IV secretion system VirB8 component
ATGAGTGAACAGAAATTAATAGCTGAATCCCGCACCTTTGAGCAGCAAAT
GATTGAGCGGGATAAACGCGCCACGAAAGCCGGTTTTGTTGTTGGCGGCG
TGGGTCTGCTGATTGCGGTACTGGCGCTCGTCGCCGTGGTCGTGATGTTG
CCGCTGAAACAGACGGACGTTGAGCTGTATACCGTGGATAACCATACAGG
ACGGGTGGAACACGTTACCCGGACATCGAAAACCAGCCTGACCGCAACAG
AAGCCTATCAAAAGGCGATGGCCGCAAACTACGTCAAAGTGCGTGAGCGG
TATGTCTATCCCTCTTTGCAGGACGACTACGAGACGGTACAGGTCTACAA
CGCTCCCCAGGTAAACGATGACTATCTGGCGCTTTATGCCGGAAAAAACG
CCCCGGACAAGGTTTATAAGAACGGGGCGCACACCGTGAAAGTGGAGATC
TTGTCCAACCAGATCACCGATGCGACAGCCCCTGATAGGGTCGCCACCAT
CCGCTACAAGAAGATTATCCGCCGTCTGGCTGATAACAGCACCCGCAACG
AATATTGGGATGCCCGGTTCACATTCCATTCTGACCCTGACAAGGAAATG
AGCGATGCGGAACGCGAGATCAACTACTTCGGCTTTACCGTCACCAGTTG
GCAGACCGACCGCGAAATCCGGGGAGGTGAATGA
>pCRY14 virB9, type IV secretory pathway VirB9 component
ATGATGAAAAAGTTAACGTTTACCGCACTGGCACTGATGATGTGCGGCGC
GGCATGGGGTGCGGCCATACCGCAGGCAAGCCGCTATGACTCCCGCATGC
AGCAGGTTATCTATAACCCGCAGAACGTCACCGTCGTTAACACCAAACCC
GGCTTTATGACAACGCTGGTATTTGATAACGATGAGGCGGTCATAAGCGC
CAGACCCGGCTTTGATGAGGCGTGGGAAGCCACGCCGGATGCAAACCGGG
TCAACGTTCGCCCGGTCGCGCTCACGCAGGGAGCGCCCGGAGAAGATGGT
AACACAACGCAGGTCGTGATCCCCCCGAACAGCCGGGACTGGCATACCAA
TATGCTGGTTGTCACCAGTAAGCGACTGTACAACGTCGAGCTGAACGTCA
TCGATGATAAATCGGCGCAGCAACCCGCTTTCCAGGTGAGCTATCGCTAT
CCGGGCGAAGAACGGGACAAAGCGAGCCGGGAGGCGACGGCCAGACAGCG
CGAGTGGGAGCAGAAACAGCAACAGGCCAGCGTCCAGAAAGCGCTGAACT
CGGCGCAGACGCCCCGCAACTGGAGTTACACCAAATATCCGGGCAAAGGC
AGTTTCAACATTGTTCCCGATTTTGCTTACGACGATGGCCGCTTTACGTT
CGTGGGCTTCTCCCCGTCTAAGTCCATTCCTTCCGTCACCAAAGAGCTGA
ACGGCAAAGAGCATGTGGTTAACAGCAGTATCCAGAAGAAAGGCGACTTC
ACCGTACTGGTGATTCAGGAAGTGACGCCCCGCCTGGTACTGCGTTCCGG
TAATGCCGTTGTGGGTCTGGAAAATAGCGGGTTTGGCAAGGTACACGCCG
CCGATGGTTCCACCGTATCCCGGCAGGTGGAAAGAGTGGAAAAACCGGAA
TCCAATTAA